NeuroPace Stock (NASDAQ:NPCE), Quotes and News Summary

Q: What sector and industry does NeuroPace (NPCE) operate in?

NeuroPace is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.

NeuroPace Stock (NASDAQ: NPCE) stock price, news, charts, stock research, profile.

Open	$8.080
Close	$8.500
Volume / Avg.	336.451K / 113.672K
Day Range	7.650 - 8.649
52 Wk Range	3.800 - 18.150
Market Cap	$244.119M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	25
Short Interest	0.72%
Days to Cover	1

Recent News

Epilepsy-Focused MedTech NeuroPace Has Attractive Entry Point, Competitive Position

Cantor Fitzgerald initiated coverage on NeuroPace Inc (NASDAQ: NPCE), a commercial-stage medical device company focused on drug-resistant epilepsy treatment through the company's responsive neurostimulation device (RNS).

Vandana Singh

Top 5 Health Care Stocks That May Fall Off A Cliff

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Lisa Levin

Why Alpha Tau Medical Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket

Gainers Tivic Health Systems, Inc. (NASDAQ: TIVC) rose 62.4% to $3.15 in pre-market trading after falling 11% on Monday. Tivic Health Systems inked a pact to make its products available on AmerisourceBergen’s third-party marketplace.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Jan

Feb

Mar

May

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy NeuroPace (NPCE) stock?

You can purchase shares of NeuroPace (NASDAQ: NPCE) through any online brokerage.

View our list of the best stock brokerages.

Who are NeuroPace's (NPCE) competitors?

Other companies in NeuroPace’s space includes: Axogen (NASDAQ:AXGN), Sight Sciences (NASDAQ:SGHT), Semler Scientific (NASDAQ:SMLR), AngioDynamics (NASDAQ:ANGO) and Fractyl Health (NASDAQ:GUTS).

What is the target price for NeuroPace (NPCE) stock?

The latest price target for NeuroPace (NASDAQ: NPCE) was reported by Cantor Fitzgerald on Thursday, May 9, 2024. The analyst firm set a price target for 18.00 expecting NPCE to rise to within 12 months (a possible 111.76% upside). 14 analyst firms have reported ratings in the last year.

Current Stock Price for NeuroPace (NPCE)?

The stock price for NeuroPace (NASDAQ: NPCE) is $8.5 last updated May 10, 2024 at 4:08 PM EDT.

Does NeuroPace (NPCE) pay a dividend?

There are no upcoming dividends for NeuroPace.

When is NeuroPace (NASDAQ:NPCE) reporting earnings?

NeuroPace’s Q2 earnings are confirmed for Tuesday, August 6, 2024.

Is NeuroPace (NPCE) going to split?

There is no upcoming split for NeuroPace.

What sector and industry does NeuroPace (NPCE) operate in?

NeuroPace is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-